![Illumina will partner with Harvard Pilgrim Health Care to offer non-invasive prenatal testing (NIPT) to women with average-risk pregnancies based on next-generation sequencing. [© zentilia/Fotolia]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1471-218x150.jpeg "Flexible and Scalable NIPT")
Flexible and Scalable NIPT
The IONA Nx uses a new fetal fraction enrichment step with the Yourgene QS250 instrument, which enriches fetal fraction by two-fold, reducing the need for as much sequencing—making it a more cost effective NIPT workflow.
SARS-CoV-2 Whole Virus and Full Process IVD Controls
The IVD controls each provide a complete validation for extraction, amplification, and detection within a molecular assay.
DNA Mutational Profiling of Tumor Samples
OnkoSight Advanced NGS testing provides targeted gene content that is aligned with the latest National Comprehensive Cancer Network (NCCN) and World Health Organization (WHO) guideline recommendations, to provide insights into many of the most common cancer types.
NGS Respiratory Research Panel
The panel includes both RNA-based and DNA-based viruses in one kit with 41,047 nucleic acid probes. It allows researchers to separate COVID-19 symptoms from those of other respiratory illnesses, both influenza- and non-influenza-related.
Home DNA Sample Collection Kit
The direct-to-patient collection kit must still be ordered by a licensed healthcare provider and clinicians can visit the online GeneSight portal to request that a kit be sent directly to the patient.
Data-Driven Precision Oncology Solutions
Sema4 Signal is a family of products and services providing data-driven precision oncology solutions with advanced analytics, digital tools, and exome-based somatic and hereditary cancer genomic tests.
Purpose-Built Biobanking LIMS for Managing COVID-19 Testing
Delivered as a comprehensive Software-As-A-Service (SaaS) solution, the LabVantage COVID-19 Biobanking Accelerator requires no infrastructure investment.
Blood-Based PD-L1 Circulating Tumor Cell Assay
The PD-L1 assay and the AccuCyte-CyteFinder system processes a single tube of blood to cells for CTC enumeration and PD-L1 biomarker expression analysis, and to plasma for optional cfDNA analysis.
COVID-19 Symptom Checker for Individual Monitoring
COVID-19 Compass is based on CDC guidelines, best clinical practices, illness severity, and risk factors such as age, gender, location, potential exposure and pre-existing health conditions.
Esophageal DNA Test for Barrett’s Esophagus
EsoGuard is designed to facilitate the diagnosis of Barrett’s Esophagus (BE) and related precursors to highly lethal esophageal adenocarcinoma (EAC).
